General Information of Drug Therapeutic Target (DTT) (ID: TTG2UMS)

DTT Name Organic cation transporter 3 (OCT3)
Synonyms Solute carrier family 22 member 3; Extraneuronal monoamine transporter; EMTH
Gene Name SLC22A3
DTT Type
Literature-reported target
[1]
UniProt ID
S22A3_HUMAN
TTD ID
T55948
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MPSFDEALQRVGEFGRFQRRVFLLLCLTGVTFAFLFVGVVFLGTQPDHYWCRGPSAAALA
ERCGWSPEEEWNRTAPASRGPEPPERRGRCQRYLLEAANDSASATSALSCADPLAAFPNR
SAPLVPCRGGWRYAQAHSTIVSEFDLVCVNAWMLDLTQAILNLGFLTGAFTLGYAADRYG
RIVIYLLSCLGVGVTGVVVAFAPNFPVFVIFRFLQGVFGKGTWMTCYVIVTEIVGSKQRR
IVGIVIQMFFTLGIIILPGIAYFIPNWQGIQLAITLPSFLFLLYYWVVPESPRWLITRKK
GDKALQILRRIAKCNGKYLSSNYSEITVTDEEVSNPSFLDLVRTPQMRKCTLILMFAWFT
SAVVYQGLVMRLGIIGGNLYIDFFISGVVELPGALLILLTIERLGRRLPFAASNIVAGVA
CLVTAFLPEGIAWLRTTVATLGRLGITMAFEIVYLVNSELYPTTLRNFGVSLCSGLCDFG
GIIAPFLLFRLAAVWLELPLIIFGILASICGGLVMLLPETKGIALPETVDDVEKLGSPHS
CKCGRNKKTPVSRSHL
Function Mediates potential-dependent transport of a variety of organic cations. May play a significant role in the disposition of cationic neurotoxins and neurotransmitters in the brain.
KEGG Pathway
Choline metabolism in cancer (hsa05231 )
Reactome Pathway
Organic cation transport (R-HSA-549127 )
Abacavir transmembrane transport (R-HSA-2161517 )

The Drug Transporter (DTP) Role of This DTT

DTT DTP Name Organic cation transporter 3 (SLC22A3) DTP Info
Gene Name SLC22A3
10 Approved Drug(s) Transported by This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetylcholine DMDF79Z Cataract 9B10 Approved [2]
Amphetamine DMSZQAK Attention deficit hyperactivity disorder 6A05.Z Approved [3]
Clonidine DM6RZ9Q Attention deficit hyperactivity disorder 6A05.Z Approved [4]
Entecavir DM7VTQO Hepatitis B virus infection 1E51.0 Approved [5]
Epinephrine DM3KJBC Acute asthma CA23 Approved [6]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [6]
Metformin DM89QE1 Colorectal carcinoma Approved [7]
Norepinephrine DMOUC09 Alopecia ED70 Approved [6]
Propranolol DM79NTF Angina pectoris BA40 Approved [4]
Sodium chloride DMM3950 Skin burns ME65.0 Approved [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Approved Drug(s)
1 Discontinued Drug(s) Transported by This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Etilefrine DM67PWD Cardiovascular disease BA00-BE2Z Withdrawn from market [9]
------------------------------------------------------------------------------------
1 Preclinical Drug(s) Transported by This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
N-methylpyridinium DMVUKEW N. A. N. A. Preclinical [10]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Guanidine DM4GO8H LambertEaton myasthenic syndrome 8C62 Investigative [10]
------------------------------------------------------------------------------------

References

1 Electrophysiological Characterization of Novel Effects of the Uptake-2 Blocker Decynium-22 (D-22) on Dopaminergic Neurons in the Substantia Nigra P... Neuroscience. 2019 Jan 1;396:154-165.
2 Organic cation transporters: physiology, toxicology and special focus on ethidium as a novel substrate. Curr Drug Metab. 2009 Jul;10(6):617-31.
3 Interaction of organic cation transporter 3 (SLC22A3) and amphetamine. J Neurochem. 2010 Jul;114(1):142-9.
4 Influx Transport of Cationic Drug at the Blood-Retinal Barrier: Impact on the Retinal Delivery of Neuroprotectants. Biol Pharm Bull. 2017;40(8):1139-1145.
5 Multiple SLC and ABC Transporters Contribute to the Placental Transfer of Entecavir. Drug Metab Dispos. 2017 Mar;45(3):269-278.
6 Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology. 2006 Jun;50(8):941-52.
7 Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology. 2009 Oct;50(4):1227-40.
8 Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci. 2004 Mar 17;24(11):2846-51.
9 Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). Biochem Pharmacol. 2005 Dec 5;70(12):1851-60.
10 Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. Am J Physiol Renal Physiol. 2000 Sep;279(3):F449-58.